5th July 2019 – Takeda Ireland, a subsidiary of Takeda Pharmaceutical Company Ltd, has officially opened a new cutting-edge manufacturing facility at its site at Grange Castle. 

Marking the event, Minister for Employment Affairs and Social Protection, Regina Doherty, Takeda Pharmaceutical CEO Christophe Weber, H.E. Mrs. Mari Miyoshi, Japanese Ambassador to Ireland and Mary Buckley, Executive Director, IDA Ireland, joined 200 guests and staff for the opening celebration.

Takeda has created this high containment, state of the art production facility dedicated to the manufacturing of their oncology treatment. Construction of the plant began in June 2017 and was managed by Project Management Group. A total of 40 jobs will be created at the site.  The plant is the first Active Pharmaceutical Ingredient (API) manufacturing operation to be located outside of Japan for Takeda and houses all steps of the production process including API, drug product and primary and secondary packaging for supply to global markets. The Takeda Grange Castle plant currently employs over 80 people, all of whom are trained in the latest manufacturing techniques, to ensure operational excellence.

Menu